58 related articles for article (PubMed ID: 23809508)
1. Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration.
Borowitz D; Gelfond D; Maguiness K; Heubi JE; Ramsey B
J Cyst Fibros; 2013 Dec; 12(6):784-5. PubMed ID: 23809508
[TBL] [Abstract][Full Text] [Related]
2. Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis.
Chiuve SE; Fife D; Leitz G; Peterson C; Campbell NM; Rennig A; Rodrigues L; Decktor D; Dowd C; Marshall BC; Borowitz D
J Cyst Fibros; 2023 Nov; 22(6):1017-1023. PubMed ID: 37880023
[TBL] [Abstract][Full Text] [Related]
3. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
[TBL] [Abstract][Full Text] [Related]
4. Association of in-line digestive enzyme cartridge with enteral feeds on improvement in anthropometrics among pediatric patients with cystic fibrosis.
Shrivastava S; Shaw K; Lee M; Reitich P; Hunter S; Klosterman M; Sathe M
Nutr Clin Pract; 2024 Mar; ():. PubMed ID: 38493301
[TBL] [Abstract][Full Text] [Related]
5. [INCIDENCE OF CONGENITAL PANCREATIC CYSTIC FIBROSIS IN A 22 1/2 MONTH OLD INFANT].
LUTSENKO SF
Pediatr Akus Ginekol; 1964; 4():31. PubMed ID: 14298572
[No Abstract] [Full Text] [Related]
6. Pancreatic Enzyme Replacement Therapy: New Hope for an Old Therapy.
Shenoy VK
Am J Gastroenterol; 2024 May; ():. PubMed ID: 38770925
[No Abstract] [Full Text] [Related]
7. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju UR; Solis-Moya A
Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
Trang T; Chan J; Graham DY
World J Gastroenterol; 2014 Sep; 20(33):11467-85. PubMed ID: 25206255
[TBL] [Abstract][Full Text] [Related]
9. Synopsis of recent guidelines on pancreatic exocrine insufficiency.
Löhr JM; Oliver MR; Frulloni L
United European Gastroenterol J; 2013 Apr; 1(2):79-83. PubMed ID: 24917944
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
Haupt ME; Kwasny MJ; Schechter MS; McColley SA
J Pediatr; 2014 May; 164(5):1110-1115.e1. PubMed ID: 24560182
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening.
Gelfond D; Heltshe SL; Skalland M; Heubi JE; Kloster M; Leung DH; Ramsey BW; Borowitz D;
J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):657-663. PubMed ID: 29176494
[TBL] [Abstract][Full Text] [Related]
12. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis.
Turck D; Braegger CP; Colombo C; Declercq D; Morton A; Pancheva R; Robberecht E; Stern M; Strandvik B; Wolfe S; Schneider SM; Wilschanski M
Clin Nutr; 2016 Jun; 35(3):557-77. PubMed ID: 27068495
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic insufficiency in Cystic Fibrosis.
Singh VK; Schwarzenberg SJ
J Cyst Fibros; 2017 Nov; 16 Suppl 2():S70-S78. PubMed ID: 28986019
[TBL] [Abstract][Full Text] [Related]
14. Exocrine Pancreatic Insufficiency in Children - Challenges in Management.
Sankararaman S; Schindler T
Pediatric Health Med Ther; 2023; 14():361-378. PubMed ID: 37908317
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
Freswick PN; Reid EK; Mascarenhas MR
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405954
[TBL] [Abstract][Full Text] [Related]
16. Impact of guideline-recommended dietitian assessments on weight gain in infants with cystic fibrosis.
Ong T; Onchiri FM; Britto MT; Heltshe SL; Kessler LG; Seid M; Ramsey BW
J Cyst Fibros; 2022 Jan; 21(1):115-122. PubMed ID: 34454845
[TBL] [Abstract][Full Text] [Related]
17. Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis.
Ng C; Major G; Smyth AR
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013488. PubMed ID: 34339047
[TBL] [Abstract][Full Text] [Related]
18. Users' Experiences of a Mobile Health Self-Management Approach for the Treatment of Cystic Fibrosis: Mixed Methods Study.
Floch J; Vilarinho T; Zettl A; Ibanez-Sanchez G; Calvo-Lerma J; Stav E; Haro PH; Aalberg AL; Fides-Valero A; Bayo Montón JL
JMIR Mhealth Uhealth; 2020 Jul; 8(7):e15896. PubMed ID: 32673237
[TBL] [Abstract][Full Text] [Related]
19. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
20. Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis.
Schechter MS; Michel S; Liu S; Seo BW; Kapoor M; Khurmi R; Haupt M
J Pediatr Gastroenterol Nutr; 2018 Oct; 67(4):520-526. PubMed ID: 30052568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
